Maja Cemazar: Key Discussions and Initiatives at the European Cancer Summit 2026
Maja Cemazar/LinkedIn

Maja Cemazar: Key Discussions and Initiatives at the European Cancer Summit 2026

Maja Cemazar, Head of Research and Education at the Institute of Oncology Ljubljana and Professor at University of Primorska, shared on LinkedIn:

“As the European Cancer Organisation European Cancer Summit 2026 comes to a close in Brussels, I leave with many thoughts and renewed motivation.

Two days of important discussions on the future of cancer care in Europe – from prevention, research and innovation to equitable access, resilient healthcare systems and the challenges facing our workforce.

A few initiatives particularly stood out to me:

The Health Literacy Grants, presented by Dr. Dégi László Csaba supporting better access to reliable information and efforts to combat misinformation.

The Women in Oncology Leadership initiative leaded by Isabel T. Rubio moving from recognising barriers to taking action towards more inclusive leadership.

The address by European Commissioner Olivér Várhelyi, highlighting the importance of cancer care on the European political agenda.

And finally, the discussions on workforce and diversity – particularly relevant in these challenging times. Supporting healthcare professionals, embracing diversity and investing in the next generation are essential for the future of cancer care.

More than ever, we need collaboration, commitment and concrete action.

Proud to be part of the European Cancer Organisation community representing Organisation of European Cancer Institutes (OECI) and grateful for the opportunity to contribute.”

Maja Cemazar: Key Discussions and Initiatives at the European Cancer Summit 2026

You can also read:

European Cancer Summit 2026: How Europe Is Building Resilient Cancer Care Systems

European Cancer Summit 2026: From Risk Reduction to Early Diagnosis: Reimagining Europe’s Cancer Prevention Pathway

European Cancer Summit 2026: From Stigma to Action: Why HPV and Hepatitis B-Related Cancer Elimination Depends on More Than Science

European Cancer Summit 2026: Investing for High Returns: Making the Economic Case for Cancer Control in Europe

Maja Cemazar: Key Discussions and Initiatives at the European Cancer Summit 2026